The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis

Annals of the Rheumatic Diseases

Volumn 67, Issue 3, 2008, Pages 296-301

  Anandarajah, A P ^a,d   Schwarz, E M ^a   Totterman, S ^b   Monu, J ^a   Feng, C Y ^a   Shao, T ^c   Haas Smith, S A ^c   Ritchlin, C T ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

^b VirtualScopics LLC   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d Clinical Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTICLE; BONE MARROW; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EDEMA; FEMALE; HISTOPATHOLOGY; HUMAN; JOINT SWELLING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOCLAST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SCORING SYSTEM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; BONE MARROW DISEASES; CELL COUNT; EDEMA; FEMALE; FINGER JOINT; HUMANS; IMMUNOGLOBULIN G; KNEE JOINT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSTEOCLASTS; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; STEM CELLS; TREATMENT OUTCOME; WRIST JOINT;

EID: 39549105629     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.076091     Document Type: Article

References (41)

1. Gladman DD. Psoriatic arthritis. In: Bellamy N, ed. Prognosis in the rheumatic diseases. Dordrecht: Kluwer Academic Publishers, 1991:153-66.
2. Kane D, Stafford L, Bresnihan B, Fitzgerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 2003;42:1460-8.
3. Resnick DNG. Psoriatic arthritis. Philadelphia, Pennyslvania: WB Saunders, 1989.
4. Ritchlin CT. Mechanisms of erosion in rheumatoid arthritis. J Rheumatol 2004;31:1356-61.
5. Anandarajah AP, Schwarz EM. Anti-RANKL therapy for inflammatory bone disorders: mechanisms and potential clinical applications. J Cell Biochem 2006;97:226-32.
6. Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM. Mechanisms of TNF-alpha and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 2003;111:821-31.
7. McQueen FM. Magnetic resonance imaging in early inflammatory arthritis: what is its role? Rheumatology (Oxford) 2000;39:700-6.
8. McGonagle D. Imaging the joint and enthesis: insights into pathogenesis of psoriatic arthritis. Ann Rheum Dis 2005;64(Suppl 2):ii58-60.
9. Olivieri I, Salvarani C, Cantini F, Scarano E, Padula A, Niccoli L, et al. Fast spin echoT2-weighted sequences with fat saturation in dactylitis if spondylarthritis; no evidence of entheseal involvement of the flexor digitorum tendons. Arthritis Rheum 2002;46:2964-7.
10. Anonti C, Dechanit C, Lorenz PDH, Wendler J. Ogilvie A, Luefti M, et al. Open label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation. Arthritis Care Res 2002;47:506-12.
11. McQueen F, Lassere M, Ostergaard M. Magnetic resonance imaging in psoriatic arthritis: a review of the literature. Arthritis Res Ther 2006;8:207.
12. McGonagle D, Gibbon W, O'Connor P, Green M, Pease C, Emery P. Characteristic magnetic resonance imaging entheseal changes in knee synovitis in spondyloarthropathy. Arthritis Rheum 1998;41:694-700.
13. Jevtic V, Watt I, Rozman B, Kos-Golja M, Demsar F, Jarh O. Distinctive radiological features of small hand joints in rheumatoid arthritis and seronegative spondyloarthritis demonstrated by contrast-enhanced (Gd-DTPA) magnetic resonance imaging. Skel Radiol 1995;24:351-5.
14. Ostergaard M, Peterfy C, Conaghan P, McQueen F, Bird P, Ejbjerg B, et al. OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheum 2003;30:1385-6.
15. McGonagle D, Conaghan PG, O'Conner P, Gibbon W, Green M, Wakefield R, et al. The relationship between synovitis and bone changes in early untreated arthritis: a controlled magnetic resonance imaging study. Arthritis Rheum 1999;42:1706-11.
16. McQueen FM, Benton N, Perry D, Crabbe J, Robinson E, Yeoman S, et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum 2003;48:1814-27.
17. Peterfy CG. Magnetic Resonance Imaging in rheumatoid arthritis: current status and future directions. J Rheumatol 2001;May 28:1134-42
18. McGonagle D, Marza-Ortega H, O'Connor P, Gibbon W, Pease C, Reece RJ, et al. The role of biomechanical factors and HLA-B27 on magnetic resonance imaging determined bone changes in plantar fascia enthesopathy. Arthritis Rheum 2002;46:489-93.
19. McGonagle D, Emery P. Enthesitis, osteitis, microbes, biomechanics and immune reactivity in ankylosing spondylitis. J Rheumatol 2000;27:2302-4.
20. Appel H, Loddenkemper C, Grozdanovic Z, Ebhardt H, Dreimann M, Hempfing A, et al. Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther 2006;8:R153.
21. Bollow M, Fischer T, Reisshauer H, Backhaus M, Sieper J, Hamm B, et al. Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroilitis-cellularity correlates with the degree of enhancement by magnetic resonance imaging. Ann Rheum Dis 2000;59:135-40.
22. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973;3:55-78.
23. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000;289:1504-8.
24. Savnik A, Malmskov H, Thomsen HS, Graff LB, Nielsen H, Danneskiold-Samsoe B, et al. MRI of the wrist and finger joints in inflammatory joint diseases at 1 year interval: MRI features to predict bone erosions. Eur Radiol 2002;12:1203-10.
25. Savnik A, Malmskov H, Thomsen HS, Graff LB, Nielsen H, Danneskiold-Samsoe B, et al. Magnetic resonance imaging of the wrist and finger joints in patients with inflammatory joint diseases. J Rheumatol 2001;28:2193-200.
26. Giovagnoni A, Grasi W, Terilli F, Blasetti P, Paci E, Ercolani P, et al. MRI of the hand in psoriatic and rheumatical arthritis. Eur Radiol 1995;5:590-5.
27. McGonagle DS, Gibbon W, O'Connor O, Green M. Pease C, Emery P. Characteristic magnetic resonance imaging entheseal changes of knee synovitis in Spondyloarthropathy. Arthritis Rheum 1998;41:694-700.
28. Jevtic V, Watt I, Rozman B, Kos-Golja M, Demsar F, Jarh O. Distinctive radiological features of small hands joints in rheumatoid arthritis and seronegative Spondarthritis demonstrated by contrast-enhanced (Gd-DPTA) magnetic resonance imaging. Skeletal Radiol 1995;24:351-5.
29. Marzo-Ortega H, McGonagle D, Rhodes LA, Tan AL, Conaghan PG, O'Connor P, et al. Efficacy of infliximab on MRI determined bone edema in psoriatic arthritis. Ann Rheum Dis 2007;66:778-81.
30. Marzo-Ortega H, McGonagle D, O'Connor P, Emery P. Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondyloarthropathy. Arthritis Rheum 2001;44:2112-17,
31. Mease PJ, Gladman DD, Ritchlin CT, Ruderman EM, Steinfeld SD, Choy EH, et al. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2005;52:3279-89,
32. Kavanaugh A, Antoni C, Gladman D, Wassenberg S, Zhou B, Beutler A, et al. The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year. Ann Rheum Dis 2006;65:1038-43.
33. Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease modifying antirheumatic drug-induced clinical remission. Arthritis Rheum 2006;54:3761-73.
34. Proulx S, Kwok E, Shealy D, Ritchlin C, Schwarz EM. 3D-MRI Quantification of the progression and amelioration of inflammatory arthritis in mice. Arthritis Rheum 54(Suppl 9):S621.
35. Jimenez-Boj E, Nobauer-Huhman I, Hansklik-Schnabel B, Dorotka R, Wanivenhaus A-H, Kainberger F, et al. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum 2007;56:1118-24.
36. Ashton EA. Quantitative medical imaging. J Imaging Sri Tech 2007;51:117-21
37. Ashton E, Takahashi C, Berg MJ, Goodman A, Totterman S, Ekholm S. Accuracy and reproducibility of manual and semi automated quantification of MS lesions by MRI. J Magn Reson Imag 2003;17:300-8.
38. Apostolova LG, Lu PH, Rogers S, Dutton RA, Hayashi KM, Toga AW, et al. 3D Mapping of mini-mental state examination performance in clinical and preclinical Alzheimer disease. Alzheimer Dis Assoc Disord 2006;20:224-31.
39. Ashton E, McShane T, Evelhoch J. Inter-operator variability in perfusion assessment of tumors in MRI using automated AIF detection. Med Image Comput Assist Interv Int Conf 2005;8:451-8.
40. Backhaus M, Burmester GR, Sandrock D, Loreck D, Hess D, Scholz A, et al. Prospective two year follow up study comparing novel and conventional imaging procedures in patients with arthritis finger joints. Ann Rheum Dis 2002;61:895-904.
41. Huang W, O'Keefe RJ, Schwarz EM. Exposure to receptor-activator of NF kappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiation. Arthritis ResTher 2003;5:R49-59.